Persistent detection of Plasmodium falciparum, P. malariae, P. ovale curtisi and P. ovale wallikeri after ACT treatment of asymptomatic Ghanaian school-children

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 3, Issue , 2013, Pages 45-50

  Dinko, Bismarck ^a   Oguike, Mary C ^a   Larbi, John A ^b   Bousema, Teun ^a,c   Sutherland, Colin J ^a,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

ACT; Asymptomatic malaria; Plasmodium malariae; Plasmodium ovale spp.

Indexed keywords

DIHYDROARTEMISININ PLUS PIPERAQUINE;

ADOLESCENT; ARTICLE; BLOOD ANALYSIS; CHILD; DRUG EFFICACY; FOLLOW UP; GHANA; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MICROORGANISM DETECTION; MICROSCOPY; MIXED INFECTION; PARASITEMIA; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE; PLASMODIUM OVALE CURTISI; PLASMODIUM OVALE MALARIA; PLASMODIUM OVALE WALLIKERI; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 84873964852     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2013.01.001     Document Type: Article

References (33)

1. Asante K.P., Zandoh C., Dery D.B., Brown C., Adjei G., Antwi-Dadzie Y., Adjuik M., Tchum K., Dosoo D., Amenga-Etego S., Mensah C., Owusu-Sekyere K.B., Anderson C., Krieger G., Owusu-Agyei S. Malaria epidemiology in the Ahafo area of Ghana. Malar. J. 2011, 10:211.
2. Bruce M.C., Macheso A., Kelly-Hope L.A., Nkhoma S., McConnachie A., Molyneux M.E. Effect of transmission setting and mixed species infections on clinical measures of malaria in Malawi. PLoS One 2008, 3:e2775.
3. Bull P.C., Pain A., Ndungu F.M., Kinyanjui S.M., Roberts D.J., Newbold C.I., Marsh K. Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity. J. Infect. Dis. 2005, 192:1119-1126.
4. Ciuca M., Lupasco G.H., Negulici E., Constantinesco P. Recherches sur la transmission expérimentale de P. malariae a l'homme. **Arch Roum Path Exp Microbiol 1964, 23:763-776.
5. Collins W.E., Jeffery G.M. Plasmodium malariae: parasite and disease. Clin Microbiol Rev 2007, 20:579-592.
6. d'Alessandro U. Progress in the development of piperaquine combinations for the treatment of malaria. Curr. Opin. Infect. Dis. 2009, 22:588-592.
7. Diallo D., Sutherland C., Nebié I., Konaté A., Ord R., Pota H., Roper C., Ilboudo-Sanogo E., Greenwood B., Cousens S. Children in Burkina Faso protected by insecticide treated materials are able to clear drug resistant parasites better than unprotected children. J. Infect. Dis. 2007, 196:138-144.
8. Djimdé A., Doumbo O.K., Traore O., Guindo A.B., Kayentao K., Diourte Y., Niare-Doumbo S., Coulibaly D., Kone A.K., Cissoko Y., Tekete M., Fofana B., Dicko A., Diallo D.A., Wellems T.E., Kwiatkowski D., Plowe C.V. Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 2003, 69:558-563.
9. Douglas N.M., Anstey N.M., Angus B.J., Nosten F., Price R.N. Artemisinin combination therapy for vivax malaria. Lancet Infect. Dis. 2010, 10:405-416.
10. Douglas N.M., Nosten F., Ashley E.A., Phaiphun L., van Vugt M., Singhasivanon P., White N.J., Price R.N. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Clin. Infect. Dis. 2011, 52:612-620.
11. Drakeley C.J., Jawara M., Targett G.A.T., Walraven G., Obisike U., Coleman R., Pinder M., Sutherland C.J. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambain children casues a significant but short-lived reduction in infectiousness for mosquitoes. Trop. Med. Int. Health 2004, 9:53-61.
12. Fançony C., Gamboa D., Sebastião Y., Hallett R., Sutherland C., Sousa-Figueiredo J.C., Nery S.V. Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in Northern Angola. Antimicrob. Agents Chemother. 2012, 56:5271-5277.
13. A head-to-head comparison of four artemisinin-based combinations for treating uncomplicated malaria in African children: a randomised trial. PLoS Med. 2011, 8:e1001119. Four ABC Study Group.
14. Fuehrer H.P., Habler V.E., Fally M.A., Harl J., Starzengruber P., Swoboda P., Bloeschl I., Khan W.A., Noedl H. Plasmodium ovale in Bangladesh: genetic diversity and the first known evidence of the sympatric distribution of Plasmodium ovale curtisi and Plasmodium ovale wallikeri in southern Asia. Int. J. Parasitol. 2012, 42:693-699.
15. Garnham P.C.C. Exo-erythrocytic schizogony in malaria. Trop. Dis. Bull. 1948, 45:831-844.
16. Garnham P.C.C. Malaria Parasites and Other Haemosporidia 1966, Blackwell Scientific Publications, Oxford, p. 1114.
17. Greenwood B.M., Armstrong J.R. Comparison of two simple methods for determining malaria parasite density. Trans. R. Soc. Trop. Med. Hyg. 1991, 85:186-188.
18. Ioset J.R., Kaur H. Simple field assays to check quality of current artemisinin-based antimalarial combination formulations. PLoS One 2009, 4:e7270.
19. Jensen A.T., Magistrado P., Sharp S., Joergensen L., Lavstsen T., Chiucchiuini A., Salanti A., Vestergaard L.S., Lusingu J.P., Hermsen R., Sauerwein R., Christensen J., Nielsen M.A., Hviid L., Sutherland C., Staalsoe T., Theander T.G. Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J. Exp. Med. 2004, 199:1179-1190.
20. Kolaczinski K., Durrani N., Rahim S., Rowland M. Sulfadoxine-pyrimethamine plus artesunate compared with chloroquine for the treatment of vivax malaria in areas co-endemic for Plasmodium falciparum and P. vivax: a randomised non-inferiority trial in eastern Afghanistan. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:1081-1087.
21. Lalloo D.G., Shingadia D., Pasvol G., Chiodini P.L., Whitty C.J., Beeching N.J., Hill D.R., Warrell D.A., Bannister B.A. HPA advisory committee on malaria prevention in UK travellers. UK malaria treatment guidelines. J. Infect. 2007, 54:111-121.
22. Mombo-Ngoma G., Kleine C., Basra A., Würbel H., Diop D.A., Capan M., Adegnika A.A., Kurth F., Mordmüller B., Joanny F., Kremsner P.G., Ramharter M., Bélard S. Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon. Malar. J. 2012, 11:120.
23. Mueller I., Zimmerman P.A., Reeder J.C. Plasmodium malariae and Plasmodium ovale - the 'bashful' malaria parasites. Trends Parasitol. 2007, 23:278-283.
24. Oguike M.C., Betson M., Burke M., Nolder D., Stothard J.R., Kleinschmidt I., Proietti C., Bousema T., Ndounga M., Tanabe K., Ntege E., Culleton R., Sutherland C.J. Plasmodium ovale curtisi and Plasmodium ovale wallikeri circulate simultaneously in African communities. Int. J. Parasitol. 2011, 41:677-683.
25. Owusu-Agyei S., Asante K.P., Adjuik M., Adjei G., Awini E., Adams M., Newton S., Dosoo D., Dery D., Agyeman-Budu A., Gyapong J., Greenwood B., Chandramohan D. Epidemiology of malaria in the forest-savanna transitional zone of Ghana. Malar. J. 2009, 8:220.
26. Shortt H.E., Garnham P.C.C. (Reproduced 2000). Demonstration of a persisting exo-erythrocytic cycle in Plasmodium cynomolgi and its bearing on the production of relapses. Bull. WHO 1948, 78:1447-1449.
27. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro I., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol. Biochem. Parasitol. 1993, 61:315-320.
28. Sutherland C.J., Hallett R. Detecting malaria parasites outside the blood. J. Infect. Dis. 2009, 199:1561-1563.
29. Sutherland C.J., Tanomsing N., Nolder D., Oguike M., Jennison C., Pukrittayakamee S., Dolecek C., Hien T.T., do Rosário V.E., Arez A.P., Pinto J., Michon P., Escalante A.A., Nosten F., Burke M., Lee R., Blaze M., Otto T.D., Barnwell J.W., Pain A., Williams J., White N.J., Day N.P., Snounou G., Lockhart P.J., Chiodini P.L., Imwong M., Polley S.D. Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J. Infect. Dis. 2010, 201:1544-1550.
30. Targett G., Drakeley C., Jawara M., von Seidlein L., Coleman R., Deen J., Oinder M., Doherty T., Sutherland C., Walraven G., Milligan P. Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J. Infect. Dis. 2001, 183:1254-1259.
31. Tarning J., Zongo I., Somé F.A., Rouamba N., Parikh S., Rosenthal P.J., Hanpithakpong W., Jongrak N., Day N.P., White N.J., Nosten F., Ouedraogo J.B., Lindegardh N. Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria. Clin. Pharmacol. Ther. 2012, 91:497-505.
32. US Pharmacopeia, 2012. (accessed 25.10.2012). https://www.usp-mc.org/monographs/dihydroartemisinin-and-piperaquine-phosphate-tablets-0-1.
33. Vinetz J.M., Li J., McCutchan T.F., Kaslow D.C. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N. Engl. J. Med. 1998, 338:367-371.